METALLOPROTEINASES ACTIVATION INVOLVEMENT IN THE PROGRESSION OF LIVER INJURY FROM NAFLD TO NASH

被引：0
|
作者：
Berardo, C. [1 ]
Palladini, G. [1 ]
Di Pasqua, L. G. [1 ]
Rizzo, V. [2 ,3 ]
Perlini, S. [1 ]
Richelmi, P. [1 ]
Vairetti, M. [1 ]
Ferrigno, A. [1 ]
机构：
[1] Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy
[2] Fdn IRCCS Policlin S Matteo, Dept Mol Med, Pavia, Italy
[3] Univ Pavia, Pavia, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2015年 / 47卷
关键词：
D O I：
10.1016/j.dld.2015.07.035
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P11
引用
收藏
页码：E233 / E233
页数：1
相关论文
共 50 条
  • [41] Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
    Kim, Hyunmi
    Lee, Da Som
    An, Tae Hyeon
    Park, Hyun-Ju
    Kim, Won Kon
    Bae, Kwang-Hee
    Oh, Kyoung-Jin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [42] EFFECT OF AGE AND GENDER IN THE PROGRESSION OF NAFLD TOWARDS NASH IN A JUVENILE MICE MODEL
    Marin, V.
    Rosso, N.
    Dal Ben, M.
    Raseni, A.
    Degrassi, C.
    Tiribelli, C.
    Gazzin, S.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E227 - E227
  • [43] A continuous-time Markov chain model of fibrosis progression in NAFLD and NASH
    Meyer, Lyndsey F.
    Musante, Cynthia J.
    Allen, Richard
    FRONTIERS IN MEDICINE, 2023, 10
  • [44] Non-alcoholic fatty liver disease (NAFLD) progression to non-alcoholic steatohepatitis (NASH) and NASH-related hepatocellular carcinoma (HCC) evolves following a differential activation of endoplasmic reticulum stress responses
    Finnemore, Alexander
    Maria Herranz, Jose
    Barace, Sergio
    Infante, Stefany
    Avila, Matias A.
    Garcia-Porrero, Guillermo
    Arcelus, Sara
    Santamaria, Eva
    Argemi, Josepmaria
    JOURNAL OF HEPATOLOGY, 2022, 77 : S697 - S697
  • [45] Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation
    Amedeo Lonardo
    Alessandro Mantovani
    Salvatore Petta
    Amedeo Carraro
    Christopher D. Byrne
    Giovanni Targher
    Nature Reviews Endocrinology, 2022, 18 : 638 - 650
  • [46] Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation
    Germani, Giacomo
    Laryea, Marie
    Rubbia-Brandt, Laura
    Egawa, Hiroto
    Burra, Patrizia
    O'Grady, John
    Watt, Kymberly D.
    TRANSPLANTATION, 2019, 103 (01) : 57 - 67
  • [47] Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
    Duarte, Sebastiao M. B.
    Stefano, Jose Tadeu
    Oliveira, Claudia P.
    ANNALS OF HEPATOLOGY, 2019, 18 (03) : 416 - 421
  • [48] The ILTS Consensus Conference on NAFLD/NASH and Liver Transplantation: Setting the Stage
    Burra, Patrizia
    Berenguer, Marina
    Pomfret, Elizabeth
    TRANSPLANTATION, 2019, 103 (01) : 19 - 21
  • [49] Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation
    Lonardo, Amedeo
    Mantovani, Alessandro
    Petta, Salvatore
    Carraro, Amedeo
    Byrne, Christopher D.
    Targher, Giovanni
    NATURE REVIEWS ENDOCRINOLOGY, 2022, 18 (10) : 638 - 650
  • [50] MONITORING OF SERUM THIOREDOXIN LEVELS IN NASH/NAFLD WITH REPEATED LIVER BIOPSY
    Kawanaka, Miwa
    Oga, Chie
    Kawamoto, Hirofumi
    Izumi, Akiyoshi
    Nakamura, Hajime
    Yodoi, Junji
    Yamada, Gotaro
    HEPATOLOGY, 2011, 54 : 1135A - 1135A
12345